Mooresville, North Carolina, United States Related Funds
| Fund Name | Location |
| Crestlight Ventures | California, Palo Alto, United States |
| Ellison Investments | - |
| First Care | - |
| NextStage | Amsterdam, Noord-Holland, The Netherlands |
| Paulig | Finland, Helsinki, Southern Finland |
| Qamcom | Göteborg, Sweden, Vastra Gotaland |
| RACCOON HOLDINGS | Japan, Tokyo |
| Shenzhenshi Longbang Shunhuoyun Daili Youxian Gongsi | China, Futian, Guangdong |
| Twist Bioscience | California, San Francisco, United States |
| Warburg Dillon Reed | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Zola Books | $5M | 02 Oct 2013 | New York, New York, United States |
– Ro Raises $500 Million in Series D Funding to Expand its Vertically Integrated Primary Care Platform
– Ro is the healthcare technology company
– The company has completed a $500 million Series D fundraising round led by existing investors General Catalyst, FirstMark Capital and TQ Ventures, with significant participation from existing investors SignalFire, Torch Capital and BoxGroup as well as new investors Altimeter Capital, Baupost Group, Dragoneer Investment Group, ShawSpring Partners, Radcliff, and 776.
– The Series D brings Ro’s total fundraising since its founding in 2017 to $876 million.
– Ro will use the newly-raised capital to strengthen its vertically integrated primary care platform.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Zola Books | $5M | 02 Oct 2013 | New York, New York, United States |
